FIELD: medicine. SUBSTANCE: agent for oral administration consists of two hormonal components placed in container. The first component consists of 5-14 daily doses containing estrogen; the second component consists of 23-14 daily doses containing the combination of estrogen compound and gestogen. One daily dose of each component has estrogen compound at dose effective for follicle maturation destroying; one daily dose of the second component has gestogen compound at amount sufficient for ovulation inhibition. Number of the first daily doses component is less then that of the second component. EFFECT: enhanced effectiveness of agent. 8 cl
